Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Health Notions

Oral Contraception Use in Benign Breast Tumor Patients in Dr. Soetomo General Academic Hospital Ayu Maghfira Nida Putri; Sjahjenny Mustokoweni; Ernawati Ernawati
Health Notions Vol 3, No 12 (2019): December
Publisher : Humanistic Network for Science and Technology (HNST)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33846/hn31202

Abstract

The growth of breast tumors is influenced by estrogen and progesterone hormones. One source of this hormone is hormonal contraception, including oral contraception which still in demand by Indonesian women. This study wants to identify oral contraception use in patients with benign breast tumors. This used descriptive study with a retrospective cross-sectional design. Samples were taken using the total sampling method in patients with benign breast tumors according to ICD 10 D-24 which was confirmed by FNAB examination at the POSA Dr. Soetomo General Academic Hospital between 2015-2017. Fifty three case of benign breast tumor were found with dominant characteristics at the age of group 40-49 years old (47.2%), had a breastfeeding history (50.9%), multiparous woman(64.2%), mean of menarche age at 13.28 years old and fertile periode women (83.0%). The most common type of benign tumors found were fibrocystic change. Patients who used oral contraceptives were 24.5% with an average length of use for 8 years 2 months, while another 75.5% used non-hormonal contraception or did not use any contraception. So the conclusion is majority of patients with benign breast tumors do not use oral contraception. Keywords: benign breast tumor; oral contraception; estrogen
Clinical Features in Metastatic Bone Disease with and without Pathological Fractures: A Comparative Study Putu Garry; Mouli Edward; Rosy Setiawati; Sjahjenny Mustokoweni; Ferdiansyah Mahyudin
Health Notions Vol 3, No 10 (2019): October
Publisher : Humanistic Network for Science and Technology (HNST)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (134.203 KB) | DOI: 10.33846/hn31001

Abstract

Background: Pathological fracture complications such as impaired clinical features is suspected to increase the mortality in MBD. In Indonesia, the habit of delayed seeking of medical treatment was common and potentially led to pathological fracture. Aim: This study compared the clinical features between MBD with and without pathological fracture. Methods: This was a retrospective study of MBD at Dr. Soetomo General Hospital in 2011-2015. We compared the clinical features by pain in Visual Analog Scale (VAS); general health presentation represented by laboratory findings; and the history of non-medical treatments. Results: 64 patients had MBD were included in this study. 37 (57.8%) of them presented with pathological fractures, and 27 (42.2%) without. Pain was the most common chief complaint (76.5%). No significant difference found between the MBD with and without pathological fracture in all variables (p=0.122; p=0.64; p=0.823; p=0.417, p=1.000 for VAS, hemoglobin, albumin, calcium, and history of non-medical treatment respectively). This probably associated with the therapy and a variety of primary tumors underlying the MBD. However, 6 out of 10 patients with history non-medical treatment presented with fractures. Conclusion: There's no significant difference in clinical features of MBD from both groups, while those with fractures had worse conditions. Keywords: Metastatic bone disease, Pathological fracture, Clinical features